Anacor Pharmaceuticals Inc (NASDAQ:ANAC)
| 5.18 Data as of Jun 19 |  -0.02 / -0.38%Today’s Change | 3.00 Today|||52-Week Range 8.25 | -0.38% Year-to-Date |
Latest ANAC News | Press Releases
No recent news for Anacor Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.20 |
| Today’s open | 5.35 |
| Day’s range | 5.11 - 5.42 |
| Volume | 350,598 |
| Average volume (3 months) | 704,487 |
| Market cap | $210.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -2.92% |
| Earnings growth (this year) | +9.52% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -47.11% |
| P/E ratio | NM |
| Price/Sales | 15.45 |
| Price/Book | 38.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SUPNSupernus Pharmaceuti... | +0.04 | +0.60% |
| PPHMPeregrine Pharmaceut... | -0.02 | -1.33% |
| --Genufood Energy Enzy... | 0.00 | 0.00% |
| ACSTAcasti Pharma Inc | +0.02 | +0.73% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $10.7M |
| Annual profit (last year) | -$56.1M |
| Net profit margin | -522.23% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director David P. Perry, MBA |
Chief Financial Officer & Senior Vice President Geoffrey M. Parker, MBA |
Corporate headquarters Palo Alto, California |
Forecasts
